Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 38, 2008 - Issue 3
157
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Preclinical absorption, distribution, metabolism and excretion (ADME) characterization of ICAM1988, an LFA-1/ICAM antagonist, and its prodrug

, , , , , , , , , , & show all
Pages 340-352 | Received 30 Sep 2007, Accepted 17 Nov 2007, Published online: 22 Sep 2008

References

  • Anderson ME, Siahaan TJ. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: Designing peptide and small molecule inhibitors. Peptides 2003; 24: 487–501
  • Beaumont K, Webster R, Gardner I, Dack K. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist. Current Drug Metabolism 2003; 4: 461–485
  • Burdick DJ, Marsters JC, Jr, Aliagas-Martin I, Stanley M, Beresini M, Clark K, McDowell RS, Gadek TR. N-benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: Structure–activity relationship of the benzoyl moiety. Bioorganic and Medicinal Chemistry Letters 2004; 14(9)2055–2059
  • Burdick DJ, Paris K, Weese K, Stanley M, Beresini M, Clark K, McDowell RS, Marsters JC, Gadek TR. N-benzoyl amino acids as LFA-1/ICAM inhibitors 1: Amino acid structure–activity relationship. Bioorganic and Medicinal Chemistry Letters 2003; 13: 1015–1018
  • Emeigh J, Gao DA, Goldberg DR, Kuzmich D, Miao C, Potocki I, Qian KC, Sorcek RJ, Jeanfavre DD, et al. Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-a]imidazol-2-one derivatives. Journal of Medicinal Chemistry 2004; 47: 5356–5366
  • Gachon F, Nicolas C, Maurizis JC, Verny M, Chabard JL, Faurie M, Gaillard G. Disposition and metabolism of letosteine in rats. Drug Metabolism and Disposition 1988; 16: 853–857
  • Gadek TR, Burdick DJ, McDowell RS, Stanley MS, Marsters JC, Paris KJ, Oare DA, Reynolds ME, Ladner C, Zioncheck KA, et al. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science 2002; 295: 1086–1089
  • Gudmundsson OS, Pauletti GM, Wang W, Shan D, Zhang H, Wang B, Borchardt RT. Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability. Pharmaceutical Research 1999; 16: 7–15
  • Keating S, Clark K, Stefanich L, Arellano F, Edwards C, Bodary, Spencer S, Gadek T, Marsters J, Jr, Beresini M. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alpha subunit of lymphocyte function associated antigen-1. Protein Science 2006; 15: 290–303
  • Liu L, Link JT, Pei Z, Reilly EB, Leitza S, Nguyen B, Marsh KC, Okasinski GF, Von Geldern TW, Ormes M, et al. Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead. Journal of Medicinal Chemistry 2000; 43: 4025–4040
  • National Institutes of Health National Research Council. Guide for the Care and Use of Laboratory Animals. 1996
  • Roberts J. Amino acids and their derivatives as radioprotective agents. Amino Acids 1992; 3: 25–52
  • Yonekawa K, Harlan JM. Targeting leukocyte integrins in human diseases. Journal of Leukocyte Biology 2005; 77: 129–140

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.